# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 71-80 of 2194 results.
Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma
Status: No longer available
Last Changed: Oct 11, 2019
First Received: Mar 22, 2016
Disease(s): Non-Hodgkin's B-cell Lymphoma
Intervention(s): MT-3724
Locations: University of Arizona, Tucson, Arizona, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
MD Anderson Cancer Center, Houston, Texas, United States
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
Status: Completed
Last Changed: Jun 09, 2017
First Received: May 08, 2009
Disease(s): B-cell Lymphoma, Indolent B-cell Lymphoma
Intervention(s): rituximab
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma
Status: Completed
Last Changed: Aug 23, 2018
First Received: Sep 15, 2005
Disease(s): B Cell Lymphoma
Intervention(s): Rituximab -CHOP plus Velcade
Locations: Hôpital Saint-Louis, Paris, Paris 10, France
Institut Gustave Roussy, Villejuif, Villejuif Cedex, France
Hôpital Henri Mondor, Créteil, France
Hôpital Lyon Sud, Pierre Bénite, France
Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jun 09, 2020
First Received: Jun 09, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,, Guangzhou, China
A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Active, not recruiting
Last Changed: May 28, 2020
First Received: Aug 28, 2014
Disease(s): Diffuse Large B-cell Lymphoma
Intervention(s): Selinexor
Locations: UACC Arizona, Tucson, Arizona, United States
University of California San Francisco, San Francisco, California, United States
University of California Los Angeles (UCLA), Santa Monica, California, United States
Boca Raton Cancer Research Medical Center, Plantation, Florida, United States
University of Chicago, Chicago, Illinois, United States
... and 147 other locations.
Mature B-Cell Lymphoma And Leukemia Study III
Status: Recruiting
Last Changed: Jun 18, 2020
First Received: Jan 12, 2010
Disease(s): Mature B-Cell Lymphoma
Intervention(s): COPAD, COP, COPD M3, CYM, COP, COPADM8, CYVE
Locations: Rady Children's Hospital San Diego, San Diego, California, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Children's Cancer Hospital, Cairo, Egypt
National University Health System, Singapore, Singapore
Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas
Status: Unknown status
Last Changed: Jan 28, 2016
First Received: Feb 26, 2013
Disease(s): Solid Tumors, B Cell Lymphoma
Intervention(s): Decitabine, cytokine-induced killer cell
Locations: Biotherapeutic Department of Chinese PLA General Hospital, Beijing, Beijing, China
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
Status: Unknown status
Last Changed: May 01, 2018
First Received: May 01, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): (R)-CHOP regimen, (R)-CVP regimen
Locations: Oncology Department of The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jun 16, 2020
First Received: Jun 16, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Lenalidomide
Locations: The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), Nanjing, Jiangsu, China
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Jan 09, 2019
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Gut microbiota samples
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, FC, Italy
Institute Of Hematology "Seràgnoli", Bologna, Italy